{"output": [["Miraca Life Sciences", "COMP", "Change_Name", "Inform Diagnostics", "COMP"], ["Miraca Life Sciences", "COMP", "Acquire", "Avista Capital Partners", "ORG"], ["Inform Diagnostics", "COMP", "Operate_In", "United States", "GPE"], ["Inform Diagnostics", "COMP", "Provide", "Pathology and Diagnostic Capabilities", "CONCEPT"], ["Inform Diagnostics", "COMP", "Impact", "Clinicians and Patients", "PERSON"], ["Scott Walton", "PERSON", "Named", "CEO", "TITLE"], ["Inform Diagnostics", "COMP", "Commit", "Highest Quality Pathology and Diagnostic Services", "CONCEPT"], ["Inform Diagnostics", "COMP", "Serve", "Patients", "PERSON"], ["Inform Diagnostics", "COMP", "Utilize", "State-of-the-art Laboratories", "FACILITY"], ["Inform Diagnostics", "COMP", "Focus", "Gastroenterology, Dermatology, Hematology, Urology, and Breast Health", "SECTOR"], ["Inform Diagnostics", "COMP", "Employ", "Subspecialist Pathologists", "PERSON"], ["Inform Diagnostics", "COMP", "Billing", "Payors", "ORG"], ["Inform Diagnostics", "COMP", "Headquartered", "Irving, Texas", "GPE"], ["Inform Diagnostics", "COMP", "Provide", "Anatomic and Clinical Pathology Services", "CONCEPT"], ["Inform Diagnostics", "COMP", "Website", "InformDx.com", "WEBSITE"]], "published": "2018-01-08T21:00:00.000+02:00"}